Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Eur Urol. 2019 Oct 21;77(2):170–177. doi: 10.1016/j.eururo.2019.08.020

Fig. 1 –

Fig. 1 –

CONSORT and treatment diagrams. (A) CONSORT diagram outlining samples used for propensity score and risk score generation and subset analyzed. (B) Flow diagram illustrating cohort treatment and AR-V7 testing history. The scoring criteria for AR-V7 positivity were prespecified, and the AR-V7 results were not released to physicians. (C) Images of the presence or absence of nuclear-localized AR-V7 protein in circulating tumor cells (CTCs).

ARSI = androgen receptor signaling inhibitor; PCWG = Prostate Cancer Clinical Trials Working Group.